Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$29,044,721
-$9,524,089 QoQ
Shares Held
3,495,153
-3.9% QoQ
Ownership
5.35%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#3
of 201 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Derivatives in ARVN
reported options exposure · as of Sep 30, 2021CallValue
$780,710
CallShares
9,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. ARVN ranks #39 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in ARVN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,044,721 | 3,495,153 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $38,568,810 | 3,638,567 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $43,753,922 | 3,689,201 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $28,517,828 | 3,347,163 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $15,829,372 | 2,150,730 | Shares | Defined | 2025-08-14 | |
| 2024-09-30 | $914,364 | 37,124 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,972,223 | 224,351 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $12,534,176 | 303,638 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,495,759 | 84,931 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $408,512 | 20,800 | Shares | Defined | 2023-11-14 | |
| 2022-09-30 | $283,712 | 6,377 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $565,563 | 13,437 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,357,104 | 20,165 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,020,232 | 61,118 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $12,791,234 | 155,649 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $780,710 | 9,500 | Call | Defined | 2021-11-15 | |
| 2021-06-30 | $731,500 | 9,500 | Call | Defined | 2021-08-16 | |
| 2021-06-30 | $8,797,789 | 114,257 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $9,076,983 | 137,322 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $5,890,574 | 69,358 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,777,147 | 75,271 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $5,345,705 | 159,383 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,832,373 | 119,910 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||